Your bully tactics will not work on my beliefs tha

Quote:

---

Your bully tactics will not work on my beliefs that this entire process and time line has been orchestrated to match up closely with supply. It did not happen organically without help and guidance from well above Nader's significant pay grade.

---

Interesting theory. And one that really tickles my brain because it suggests our approval is imminent and that all of our hand-wringing has been for naught.

To be honest, I really appreciate your thinking and analysis Rubraquercus, so I'd be interested in your thoughts regarding a couple of issues that are difficult for me reconcile.

If the "entire process and time line has been orchestrated to match up closely with supply", then:

1. Why was CytoDyn provided absolutely no funding and no assistance in enrolling our trials?

Regeneron has received "$160 million in federal money the company had already received to run clinical trials and ramp up manufacturing."
Source: https://www.nytimes.com/2020/07/09/health/reg...odies.html

2. Why is CytoDyn producing only 1.2M vials of leronlimab this year, with a paltry 30k vials expected in July (capable of treating only 7,500 patients), followed by 200-300k vials per month starting at the end of August or early September, and running until the end of the year.

Again, Regeneron has received "$160 million in federal money the company had already received to run clinical trials and ramp up manufacturing."
Source: https://www.nytimes.com/2020/07/09/health/reg...odies.html

3. Why hasn't the federal government purchased all of CytoDyn's current or anticipated inventory of leronlimab?

The US awarded Regeneron "$450 million to manufacture and supply as many as 300,000 doses as treatments or 1.3 million doses to prevent infection.
Source: https://www.nytimes.com/2020/07/09/health/reg...odies.html

4. Why did the federal government allow CytoDyn's alleged production capacity to dramatically and progressively erode in the following sequence?

- On April 28, Dr.NP claimed that AGC would hopefully begin delivering 600-700k vials
beginning in June/July, and Samsung might be able to produce 5M vials by August/September.

- Approximately one month later, Dr.NP claimed Samsung can produce 1.2M vials with the possibility of 2-3M additional vials by the end of the year.

- A week ago, Dr.NP claimed Samsung is now "booked" and that there will be a grand total of 1.1M vials this year.

- And somehow, there's has been no further mention of AGC production. It has completely fallen off the grid and no one has asked about in in any CC call.


These are the proverbial "flies in the ointment" for me. And as much as I like your theory, I really do, these nagging issues make it hard for me to adopt.